Baylor Cancer Hospital

Dallas, Texas 75246

0 studies enrolling now · 2 studies all time

What they study most

Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma, Relapsed/Refractory Mantle Cell Lymphoma

Studies at this site

• Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) — Completed
• Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma — Stopped early